Jefferson University Hospitals

Provider Profile

Thomas R. Klumpp, MD

Jefferson University Physician

Academic Title: Professor
Medical Director for Cancer Informatics

Medical Oncology - Hematologic Malignancies (Not Accepting New Patients)
Medical Oncology - Leukemia/Lymphoma (Not Accepting New Patients)
Medical Oncology (Not Accepting New Patients)

Office Locations

925 Chestnut Street
Suite 320A
Philadelphia PA 19107
Phone: (215) 955-8874
Fax: (215) 503-7697

Medical Services

Board Certifications

  • Medical Oncology
  • Hematology
  • Internal Medicine

Hospital Affiliation / Admitting Privileges

  • Thomas Jefferson University Hospital
  • Methodist Hospital Division of Thomas Jefferson University Hospital

Personal Statement

I take care of patient's physical, emotional and spiritual needs.


  • University of Pennsylvania School of Medicine, Medical School


  • Dartmouth Medical Center


  • Dartmouth Medical Center


  • Massachusetts General Hospital, Boston, MA
  • Dana Farber Cancer Institute

Jefferson physicians accept most health insurance plans, including those listed below. However, plan acceptance may vary by practice and may be subject to change. If you have questions about whether a specific physician accepts your insurance, please contact your insurance company.

Insurances Accepted

  • Aetna PA Employee Benefit Trust Fund (PEBTF)
  • Consumer Health Network PPO
  • CorVel
  • Employers Health Network PPO
  • Geisinger Health Plan
  • Health Management Network PPO
  • HumanaChoicePPO,Medicare,GoldPlusHMO
  • Keystone First VIP Choice
  • Mercy LIFE
  • PlanCare America
  • Prime Health Services, Inc.
  • UPMC HMO,PPO ReadingHspEmpONLY
  • UPMC Medicare HMO
  • US Family Health Plan

Recent Publications

Higher rates of relapse in maternal recipients of haploidentical hematopoietic stem cell transplantation from adult offspring donors for AML and myelodysplastic syndrome

Acquired uniparental disomy in chromosome 6p as a feature of relapse after T-cell replete haploidentical hematopoietic stem cell transplantation using cyclophosphamide tolerization

Donor Lymphocyte Infusion in Hematologic Malignancies - Good to be Fresh?

Hematopoietic Cell Transplantation Outcomes in Monosomal Karyotype Myeloid Malignancies

Impact of chronic graft-versus-host disease on late relapse and survival on 7,489 patients after myeloablative allogeneic hematopoietic cell transplantation for leukemia

Center for international blood and marrow transplant research chronic graft-versus-host disease risk score predicts mortality in an independent validation cohort

Increasing Incidence of Chronic Graft-versus-Host Disease inAllogeneic Transplantation: A Report from the Center for International Blood and Marrow Transplant Research

Older Patients with Myeloma Derive Similar Benefit from Autologous Transplantation

Electronic medical records and quality of cancer care

Providing personalized prognostic information for adult leukemia survivors

HLA DR15 Antigen Status Does Not Impact Graft-versus-Host Disease or Survival in HLA-Matched Sibling Transplantation for Hematologic Malignancies

Outcome of Lower-Intensity Allogeneic Transplantation in Non-Hodgkin Lymphoma after Autologous Transplantation Failure

Spontaneous graft versus host disease occurring in a patient with multiple myeloma after autologous stem cell transplant

Classifying Cytogenetics in Patients with Acute Myelogenous Leukemia in Complete Remission Undergoing Allogeneic Transplantation: A Center forInternational Blood and Marrow Transplant Research Study

Risk factors associated with increased nonrelapse mortality and with poor overall survival in children with chronic graft-versus-host disease

Chronic GVHD risk score: A Center for International Blood and Marrow Transplant Research analysis

Comparable survival after HLA-well-matched unrelated or matched sibling donor transplantation for acute myeloid leukemia in first remission with unfavorable cytogenetics at diagnosis

The outcome of full-intensity and reduced-intensity conditioning matched sibling or unrelated donor transplantation in adults with Philadelphia chromosome-negative acute lymphoblastic leukemia in first and second complete remission

A Comparison of HLA-Identical Sibling Allogeneic versus Autologous Transplantation for Diffuse Large B Cell Lymphoma: A Report from the CIBMTR

Impact of ABO mismatching on the outcomes of allogeneic related and unrelated blood and marrow stem cell transplantations for hematologic malignancies: IPD-based meta-analysis of cohort studies